Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haijun Li

Showing results (421-430 of 422) with videos related to

Pageof 43
Sort By:
You have reached the last page of results.This site can display upto 422 results.
Eclinicalmedicine|January 8, 2024
Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trialYangqing Zhan, Zhengshi Lin, Jingyi Liang, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|January 24, 2021
Clinical characteristics, rates of blindness, and geographic features of PACD in ChinaHui Zhang, Kai Cao, Hongyan Jia, et al.
Pageof 43

Showing results (421-430 of 422) with videos related to

Sort By:
Pageof 43
You have reached the last page of results.This site can display upto 422 results.
Eclinicalmedicine|January 8, 2024
Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trialYangqing Zhan, Zhengshi Lin, Jingyi Liang, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|January 24, 2021
Clinical characteristics, rates of blindness, and geographic features of PACD in ChinaHui Zhang, Kai Cao, Hongyan Jia, et al.
Pageof 43